A bowel screening pilot is underway in the Waitemata District Health Board area. The Pilot runs until December 2017.
Since late 2011, the Bowel Screening Pilot has been offering bowel screening to eligible people aged 50 to 74 years living in the Waitemata DHB area.
The National Bowel Screening Programme (NBSP) will be rolled out across all DHBs starting in July 2017. The Waitemata Pilot will transition to the National Bowel Screening Programme in January 2018.
The eligible age range for the national programme will be 60 to 74 years. More than 80% of cancers detected through the Pilot have been found in this age range.
As part of the Pilot transition, eligible people aged 50 to 74 years who are living in the Waitemata DHB area will continue to be invited for screening until the Pilot ends in December 2017. People in the 50 to 74 year age range who have received an invitation through the Pilot will continue to be invited to complete a bowel screening test every two years, while they’re still eligible.
From July 2017, the same positivity threshold (the amount of blood in the sample that triggers a positive result) will be used for the Pilot as for the National Bowel Screening Programme.
People living in the Waitemata DHB area who have not turned 50 by the end of the Pilot and have not been invited to participate in the Pilot, will be invited to be screened as part of the National Bowel Screening Programme once they’ve turned 60, if they’re eligible for publicly funded health care.
Budget 2010 committed $24 million over four years for the Bowel Screening Pilot. Budget 2015 invested a further $12.4 million to extend the Pilot to December 2017.
Why New Zealand is doing this pilot
Bowel cancer is one of New Zealand’s most common cancers and the second highest cause of cancer death.
More than 3000 New Zealanders are diagnosed with bowel cancer each year and more than 1200 die from it.
Bowel screening can detect cancer at an early stage when it can often be successfully treated.
Information from the Waitemata DHB Bowel Screening Pilot has helped to inform decisions about the National Bowel Screening Programme.
Data collected during the Pilot has provided vital information on participation levels, cancer detection rates and the impact on health services.
It is best practice internationally to pilot a screening programme before offering it more widely, to ensure it is safe for participants, there is capacity to provide timely diagnostic and treatment services and that all processes are working correctly.